Literature DB >> 15008966

Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

R B Moss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15008966      PMCID： PMC1808975          DOI： 10.1111/j.1365-2249.2003.02389.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  42 in total

1.  Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder.

Authors:  T S Blackwell; A A Stecenko; J W Christman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

2.  Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa.

Authors:  C Hubeau; M Lorenzato; J P Couetil; D Hubert; D Dusser; E Puchelle; D Gaillard
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

3.  The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type.

Authors:  C Moser; S Kjaergaard; T Pressler; A Kharazmi; C Koch; N Høiby
Journal:  APMIS       Date:  2000-05       Impact factor: 3.205

4.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines.

Authors:  D Kube; U Sontich; D Fletcher; P B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

5.  Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages.

Authors:  Jindrich Soltys; Tracey Bonfield; James Chmiel; Melvin Berger
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

6.  Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid.

Authors:  R Bals; D J Weiner; R L Meegalla; F Accurso; J M Wilson
Journal:  Am J Respir Cell Mol Biol       Date:  2001-07       Impact factor: 6.914

7.  Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis.

Authors:  C Hubeau; E Puchelle; D Gaillard
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

8.  Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes.

Authors:  R B Moss; Y P Hsu; L Olds
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

9.  Peripheral decrease and pulmonary homing of CD4+CD45RO+ helper memory T cells in cystic fibrosis.

Authors:  M Häusler; K Schweizer; S Biesterfel; T Opladen; G Heimann
Journal:  Respir Med       Date:  2002-02       Impact factor: 3.415

10.  G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages.

Authors:  G R Thomas; E A Costelloe; D P Lunn; K J Stacey; S J Delaney; R Passey; E C McGlinn; B J McMorran; A Ahadizadeh; C L Geczy; B J Wainwright; D A Hume
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422
View more
  2 in total

1.  Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.

Authors:  Yaqin Xu; Anja Krause; Hiroko Hamai; Ben-Gary Harvey; Tilla S Worgall; Stefan Worgall
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

2.  Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.

Authors:  Veerle Reynders; Stefan Loitsch; Constanze Steinhauer; Thomas Wagner; Dieter Steinhilber; Joachim Bargon
Journal:  Respir Res       Date:  2006-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.